T M Harris
Overview
Explore the profile of T M Harris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
1485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raffa E, Raffa E, Harris T, Harris T, Choed-Amphai C, Choed-Amphai C, et al.
Transplant Cell Ther
. 2024 Dec;
31(3):180.e1-180.e12.
PMID: 39722321
Allogeneic hematopoietic stem cell transplantation is challenging for patients with transfusion-dependent thalassemia who have experienced iron overload and received chronic transfusion support. A transplantation strategy including a reduced-intensity preparative regimen...
2.
3.
Harris T
Buffalo Med J Mon Rev Med Surg Sci
. 2022 Apr;
4(6):393-394.
PMID: 35374541
No abstract available.
4.
Harris T, Bowen A, Holt D, Sarovich D, Stevens K, Currie B, et al.
Clin Microbiol Infect
. 2018 May;
24(9):1027-1029.
PMID: 29723570
No abstract available.
5.
Harris T, Harris C, Kuzma P, Lee J, Mahalingam S, Gilbreath S
J Am Chem Soc
. 2011 Dec;
110(18):6186-92.
PMID: 22148798
No abstract available.
6.
Harris T, Harris C, Oster T, Brown L, Lee J
J Am Chem Soc
. 2011 Dec;
110(18):6180-6.
PMID: 22148797
No abstract available.
7.
Gilbreath S, Harris C, Harris T
J Am Chem Soc
. 2011 Dec;
110(18):6172-9.
PMID: 22148796
No abstract available.
8.
Harris T, Harris C
Curr Protoc Nucleic Acid Chem
. 2008 Apr;
Chapter 1:Unit 1.3.
PMID: 18428818
Syntheses of N2-substituted nucleosides have been studied for many years, primarily with ribonucleosides. However, the primary route to these compounds requires acidic conditions that are too vigorous for the acid-labile...
9.
Kanuri M, Finneman J, Harris C, Harris T, Lloyd R
Environ Mol Mutagen
. 2002 Jan;
38(4):357-60.
PMID: 11774368
No abstract available.
10.
Rodriguez D, Kowalczyk A, Ward Jr J, Harris C, Harris T, Lloyd R
Environ Mol Mutagen
. 2002 Jan;
38(4):292-6.
PMID: 11774359
The National Toxicology Program has recently classified 1,3-butadiene (BD) as a human carcinogen. BD is metabolized to the intermediates 1,2-epoxy-3-butene (EB), 1,2:3,4-diepoxybutane (DEB), and 1,2-dihydroxy-3,4-epoxybutane. All three metabolites have been...